Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Queensland Health
Medtronic
Accenture
Mallinckrodt
Express Scripts
Colorcon
McKesson
Federal Trade Commission

Generated: July 20, 2018

DrugPatentWatch Database Preview

Dibucaine hydrochloride - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for dibucaine hydrochloride and what is the scope of dibucaine hydrochloride patent protection?

Dibucaine hydrochloride
is the generic ingredient in one branded drug marketed by Novartis and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for dibucaine hydrochloride
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Bulk Api Vendors: 64
Patent Applications: 1,996
DailyMed Link:dibucaine hydrochloride at DailyMed
Medical Subject Heading (MeSH) Categories for dibucaine hydrochloride
Synonyms for dibucaine hydrochloride
012D735
2- paragraph sign inverted exclamation markNo>>u-N-(2- paragraph signthornOO degrees +/-OO>>u)-4-a-sso(1/4)xo pound degrees . NIEaNI
2-Butoxy-N-(2-(diethylamino)ethyl)quinoline-4-carboxamide hydrochloride
2-Butoxy-N-(2-diethylaminoethyl)-4-quinolinecarboxamide hydrochloride
2-butoxy-N-(2-diethylaminoethyl)quinoline-4-carboxamide hydrochloride
2-Butoxy-N-[2-(diethylamino)-ethyl]-4-quinoline carboxamide hydrochloride
2-butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide hydrochloride
2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide monohydrochloride
2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide monohydrochloride; 2-Butoxy-N-(2-diethylaminoethyl)cinchoninamide hydrochloride
2-butoxy-N-[2-(diethylamino)ethyl]quinoline-4-carboxamide hydrochloride
2-butoxy-N-[2-(diethylamino)ethyl]quinoline-4-carboxamide;hydrochloride
4-quinolinecarboxamide, 2-butoxy-N-[2-(diethylamino)ethyl]-, hydrochloride (1:1)
61-12-1
A833051
AB0012106
AB1004834
AC-15501
AC1LAWAM
AK326166
AKOS015897111
AN-23641
API0002315
AS-12541
BCP0726000008
BCP9000604
Benzolin (local anesthetic)
Butoxycinchoninic acid diethylethylenediamide hydrochloride
C 3225
C20H29N3O2.HCl
CCG-40219
CHEBI:59735
CHEMBL1200612
Cincaine chloride
Cincaine hydrochloride
Cinchocaine HCL
Cinchocaine hydrochloride
Cinchocaine Hydrochloride 1.0 mg/ml in Methanol (as free base)
Cinchocaine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Cinchocainium chloride
Cinchokain hydrochlorid
Cinchokain hydrochlorid [Czech]
CINCHONINAMIDE, 2-BUTOXY-N-(2-(DIETHYLAMINO)ETHYL)-, MONOHYDROCHLORIDE
CS-2657
CTK8F9136
D02220
Dibucaine (Cinchocaine) HCl
Dibucaine (hydrochloride)
Dibucaine HCl
Dibucaine hydrochloride (JP17/USP)
Dibucaine hydrochloride [USP:JAN]
Dibucaine hydrochloride, analytical standard, >=99%
Dibucaine hydrochloride, United States Pharmacopeia (USP) Reference Standard
EBD27501
EINECS 200-498-1
FT-0666517
Heavy Solution Nupercaine
HMS1920E14
HY-B0552A
I08-0084
KS-00000F9B
MCULE-2036117305
MFCD00012735
MLS000028429
MLS001076275
MolPort-003-666-160
N-[2-(diethylamino)ethyl](2-butoxy(4-quinolyl))carboxamide, chloride
NCGC00094647-01
NCGC00094647-02
NCGC00094647-03
NSC-756724
NSC756724
Nupercaine hydrochloride
Nupercaine hydrochloride (TN)
Opera_ID_1096
Percain
Percaine
Percamin (TN)
Percamin S
Pharmakon1600-01500236
PubChem20328
Q-100001
s4038
SC-26885
SCHEMBL31303
SMR000058369
Sovcain
Sovcainum
SPECTRUM1500236
ST50319978
UNII-Z97702A5DG
Z97702A5DG

US Patents and Regulatory Information for dibucaine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis HEAVY SOLUTION NUPERCAINE dibucaine hydrochloride INJECTABLE;INJECTION 006203-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
US Army
US Department of Justice
McKesson
Deloitte
AstraZeneca
Medtronic
Cipla
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.